ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1105

Bone Metabolism in Rheumatic Diseases May be Affected By Free Fatty Acids

Klaus W. Frommer1, Andreas Schäffler2, Uwe Lange3, Stefan Rehart4, Jürgen Steinmeyer5, Markus Rickert6, Ulf Müller-Ladner7 and Elena Neumann1, 1Justus-Liebig-University Giessen, Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Bad Nauheim, Germany, Bad Nauheim, Germany, 2Department of Internal Medicine III, Endocrinology, Diabetes, Metabolism, Justus-Liebig-University of Giessen, Bad Nauheim, Germany, 3Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 4Orthopedic & Trauma Surgery, Agaplesion Markus-Hospital, Frankfurt, Frankfurt, Germany, 5Dept Orthopedics and Experimental Orthopedics, University Hospital of Giessen and Marburg, Giessen, Germany, 6Dept of Orthopedics and Orthopedic Surgery, University Hospital of Giessen and Marburg, Gießen, Germany, 7Justus-Liebig-University Giessen, Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Bad Nauheim, Germany, Bad-Nauheim, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: adipose tissue, Bone, osteoblasts and osteoclasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Biology and Pathology of Bone and Joint - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Obesity is associated with an increased risk of osteoarthritis also in non-weight bearing joints and increased amounts of visceral fat are associated with lower bone density. This observation and the association of chronically elevated free fatty acid (FFA) serum levels with a number of inflammatory cardiovascular and metabolic diseases suggest that FFA may also play a role in inflammation-related bone loss. We therefore analyzed the effect of FFA on the central cells of bone metabolism, i.e. osteoblasts and osteoclasts, in the context of rheumatic diseases.

Methods: Primary osteoblasts (OB) were isolated from cancellous bone of OA and RA patients undergoing knee joint surgery. Osteoclasts (OC) were differentiated from peripheral blood mononuclear cells (PBMC). OB and OC were stimulated with the saturated FFA palmitic acid (PA) and the unsaturated FFA linoleic acid (LA). Immunoassays were used to quantify protein secretion. mRNA expression levels were quantified by real-time PCR. Mineralization activity was quantified using Alizarin Red S staining, differentiated OC were quantified by counting TRAP-positive multinuclear cells. Toll-like receptor (TLR) 4 and TLR2 were blocked by neutralizing antibodies.

Results: OB secreted increased amounts of the proinflammatory cytokine IL-6 (up to 9-fold ­) as well as the chemokines IL-8 (up to 221-fold ­), GRO-a (from below detection level to detectable levels) and MCP‑1 (up to 16-fold ­) upon stimulation with PA or LA. The degree of response was highly dependent on the patient. RANKL as well as OPG, important regulators of osteoclastogenesis and OC activity, remained unaffected by FFA on protein and mRNA level. OB activity appeared unaffected because alkaline phosphatase (ALP) and collagen type I mRNA expression as well as production of inorganic matrix was not altered. Differentiation markers of OB (e.g. osteocalcin) also remained unchanged after FFA stimulation. PA-induced IL-8 secretion by OB could be significantly reduced by TLR4 blockade (by 93%), while blocking TLR2 had no effect. Secretion of IL-8 by RA OC was increased by FFA, while MMP-9 was reduced. The number of TRAP positive multinuclear cells decreased (by around 50%). However, markers of osteoclast activity (CLCN7, CTSK, TCIRG) remained unchanged at the mRNA level.

Conclusion: Our results clearly suggest a pro-inflammatory effect of certain FFA on osteoblasts and osteoclasts. While this can indirectly contribute to bone loss, the reduced number of mature OC after FFA stimulation suggests an inhibitory effect on bone resorption. The effect of FFA on cells of bone metabolism therefore appears to be divergent. The effects on osteoblasts are at least in part mediated by TLR4, while TLR2 is not involved.


Disclosure: K. W. Frommer, None; A. Schäffler, None; U. Lange, None; S. Rehart, None; J. Steinmeyer, None; M. Rickert, None; U. Müller-Ladner, None; E. Neumann, None.

To cite this abstract in AMA style:

Frommer KW, Schäffler A, Lange U, Rehart S, Steinmeyer J, Rickert M, Müller-Ladner U, Neumann E. Bone Metabolism in Rheumatic Diseases May be Affected By Free Fatty Acids [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/bone-metabolism-in-rheumatic-diseases-may-be-affected-by-free-fatty-acids/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-metabolism-in-rheumatic-diseases-may-be-affected-by-free-fatty-acids/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology